Vascular Neurology   

Family history is notable for CVA and early onset MI in nonsmokers, but no personal or family history of VTE. APLS testing is negative. Previously fou...

Labs with normal PT, but prolonged PTT (47 sec, ULN 40 sec) that does not correct on immediate mix. Lupus anticoagulant negative (DRVVT and hexagonal ...

Thrombophilia testing, including JAK2 is negative. When would you stop anticoagulation?

When do you determine SSRI therapy is unsafe to pursue in such situations?

Should some patients get 325 mg instead of 81mg at least for a certain amount of time, such as patients in the acute phase of ischemic stroke or patie...

Considering the short half-life, at what point would it be deemed too late to administer any reversal agent, and to consider withholding it?

In light of ANNEXA-I RCT results: Connolly et al., PMID 38749032.

Are there specific mass features that would influence your treatment decision?

When would you consider using anticoagulation and for how long?

Is there any evidence supporting the use of heparin boluses?

The ASH 2020 guidelines have "recommended that adults with HbSS or HbSβ0 thalassemia be screened at least once for silent cerebral infarcts even ...

In FRAIL-AF, switching VKA therapy to a NOAC was associated with higher risk of bleeding in elderly, frail patients. 

In FRAIL-AF, participants were switched from VKA to dabigatran, rivaroxaban, apixaban, and edoxaban.

Also how would you manage this perioperatively?

The patient has no known history of autoimmune disease.

Do we prophylactically place patients on anticoagulation after one episode? Besides MRI/MRV brain, are there other diagnostic imaging that should b...

In the setting of no personal or family history and no other risk factors for thrombosis, is systemic anticoagulation warranted if local treatments (e...

How do you approach secondary stroke prevention for patients with ischemic stroke, atrial fibrillation, and signs of cerebral amyloid angiopathy/micro...